Andrew Fish is a President & CEO, Medical Device Innovation Consortium at Medical Device Innovation Consortium (MDIC). He possess expertise in public affairs, legislative relations, strategy, legislation, strategic planning and 14 more skills. Colleagues describe him as "As Managing Director for Science Policy and Government Relations at the American Association for Cancer Research, I am writing to compliment Andy Fish's leadership and professionalism, as the AACR had the opportunity to partner with AdvaMedDx on a very important all-day symposium that examined the importance of cancer diagnostics in improving cancer care. It was an absolute pleasure working with Andy and his colleagues on this symposium. He is just an extremely smart, hardworking, and gracious leader. I look forward to continuing to work with Andy and the excellent organization he oversees on some very important issues that are key to improving care for cancer patients.", "It has been a pleasure to work with Andy. My organization, the Society for Women's Health Research worked with him in his position at AdvamedDx on a molecular diagostics campaign. He was incredibly response and helpful, very professional and reliable and we look forward to working with him in the future.", and "Andy's leadership was central to building AdvaMedDx into a vibrant and forward-looking organization for the diagnostics industry. Some of the most important elements of Andy's efforts included the execution of a robust program that raised the profile of the industry on Capitol Hill as an essential component of the US healthcare ecosystem in preventing and managing disease. He focused much of AdvaMedDx's outreach on the priorities of policy makers such as reducing infection, cancer prevention and personalized medicine. He helped drive an ideas-based agenda which helped to build the reputation of the industry as a collaborative partner in advancing patient and public health. Importantly, Andy helped to shepherd many of the organization's proposals into successful legislative and regulatory initiatives that advance both innovation and public health. These successful efforts attracted many new members to the organization making AdvaMedDx both a policy shaping and organizational success. Finally, Andy does a great job of working with the AdvaMedDx board and company staff to keep them informed and focused on key priorities."